ENA-001 is under clinical development by Enalare Therapeutics and currently in Phase II for Coronavirus Disease 2019 (COVID-19).

The device clearly has the potential to meet an important need. Each year, more than a quarter-million preterm infants in the United States have a diagnosis of apnea of prematurity, and there are many ...

What is apnea of prematurity? Apnea of prematurity occurs when newborns, especially those born prematurely, stop breathing for short periods of time. Apnea can be caused by immaturity of the brain and ...

Hypertension can lead to serious health issues without presenting noticeable symptoms. Despite this, it remains one of the ...

neonatal apnea, cardiovascular problems, and complications arising from prematurity. Division faculty members are active in many research endeavors including the 17-center Neonatal Research Network ...

The results of polysomnography in patients without OSA revealed central sleep apnea (4%), behavioral sleep ... Family History of Premature CAD Mortality Despite the similar proportion of subjects ...

Advertisement The new study also showed that abuse experienced in pregnancy can raise risks for maternal substance abuse, premature delivery ... to treat sleep apnea Dec. 21 (UPI) -- Zepbound ...

Apnea of prematurity is a disorder in infants who are preterm that is defined as cessation of breathing (apnea) that lasts for more than 20 seconds and/or is accompanied by hypoxia or bradycardia.

For example, some babies are given caffeine to help treat apnea of prematurity. A recent study found that premature infants treated with caffeine in the NICU had improved lung function at age 11, ...